
Build Your Quality Management System
Build a lean, scalable QMS to comply with ISO 13485, MDSAP, FDA, and MDR requirements, with personalized guidance from quality experts every step of the way
Confirm your medical device classification and global market entry pathway. Leave with a documented regulatory strategy and intended use statements to support your investor due diligence.

By the end of this program, you will have a clear regulatory strategy and timeline you can execute against and share with stakeholders.
Product classification across FDA, Health Canada, and EU MDR
A documented regulatory pathway with submission requirements
Precise intended use and indications for use statements
A phased global commercialization timeline with regulatory dependencies
An investor-ready regulatory milestone document
“As an early-stage medtech company navigating regulatory readiness, having a structured system with clear guidance made a huge difference. The templates were practical and startup-friendly, the process was easy to follow, and the support helped us understand not just what needed to be done, but how to do it properly.”

Founder & COO • Cellect
“Rellia has been excellent to work with and has played an integral role in building our regulatory plans. I would highly recommend them to anyone looking to navigate regulatory submissions for a medical-related product. They are true experts in their field.”

Founder & CEO • Neuro-Mod
Work with regulatory experts to classify your device, choose the right pathway, and build a timeline investors trust.
Determine your product's device classification across FDA, Health Canada, and EU MDR — and map the fastest viable regulatory pathway for each market.
Draft precise intended use and indications for use statements that align your regulatory, clinical, and commercial strategy from the start.
Build a phased commercialization timeline across key markets, understanding the regulatory dependencies and milestones investors expect to see.
Pathway Clarity
Understand exactly which regulatory submissions you need, in what order, and what evidence each requires.
Risk-Based Approach
Use ISO 14971 risk management principles to inform your classification and submission strategy from day one.
Investor Alignment
Frame your regulatory strategy as a de-risking milestone that builds investor confidence in your timeline.
Actionable Roadmap
Leave with a documented regulatory strategy and timeline you can execute against and share with stakeholders.
4 weeks to build your regulatory roadmap from classification to market
Leave with a documented regulatory strategy and milestone timeline you can execute against and share with investors.
Many health tech products require regulatory clearance — but not all do. Reach out and we'll help you figure out where you stand.